The pricing standoff between government and industry has stalled research and put thousands of jobs at risk The pricing standoff between government and industry has stalled research and put thousands of jobs at risk ‘W e want to see more investment flow to Britain,” the chancellor, Rachel Reeves, urged of big pharmaceutical companies this month, as she indicated that the government was willing to increase the price it pays for NHS drugs. Ministers are likely to announce a rethink on pricing